| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |